Global Market for Women’s Health Devices Sees Moderate Growth

These are the latest findings of GlobalData (London, United Kingdom), an international business intelligence provider.

The market encompasses treatments for conditions that are particular to the adult female anatomy; this includes abnormal uterine conditions, such as menorrhagia and uterine fibroids, pelvic disorders such as female stress urinary incontinence, and anti-conceptive procedures. Minimally invasive technologies to treat these conditions as alternatives to conventional surgery are expected to see increased adoption in the coming years, due to increased physician and patient awareness and an increasing number of women proactively seeking treatment.

Technologies include endometrial resection devices, uterine fibroid embolization agents, female sterilization devices, and female urinary incontinence slings. As more women seek treatment for uterine health and incontinence issues, the market will become increasingly competitive, provided that the new technology meets efficacy and safety standards. However, recent lawsuits related to safety issues with some of these devices have received widespread media attention, particularly in the urinary incontinence sling market, causing some skepticism.

“The understanding that a woman’s quality of life can be vastly improved by new technologies coincides with the awareness that a variety of new treatment options, such as global endometrial ablation and uterine artery embolization, are far less invasive than surgery,” said GlobalData analyst Premdharan Meyyan. “For women who suffer from abnormal uterine conditions, such as heavy menstrual bleeding and uterine fibroids, these new technologies offer safe and effective alternative treatment options to patients who do not wish to undergo invasive surgery.”

Related Links:
GlobalData